Thentia now working with AWS to drive innovation in the public sector
Working with AWS extends the reach of Thentia Cloud to an expanding global community of agencies and regulatory entities seeking to embrace IT modernization through their preferred cloud provider. OKLAHOMA CITY, Jan. 19, 2024 /PRNewswire/ – Thentia, a leading innovator in regulatory technology
AI in Media & Entertainment – The Accelerated Integration of AI in Media Value Chains and Future Developments
DUBLIN, Jan. 19, 2024 /PRNewswire/ — The “AI in Media & Entertainment – Impact of AI Across the Value Chain” report has been added to ResearchAndMarkets.com’s offering. In an era where technology and digital innovation continuously reshape industries, the media an
Big waves hit the aesthetics world today as Debra K. Menke Launches DKM Aesthetics, a Disruptive Distribution Company Focused on Wellbeing and Lifestyle Brands in the Professional Aesthetics Market
DES MOINES, Iowa, Jan. 19, 2024 /PRNewswire/ — Award-winning sales leader, former financial advisor, and celebrated author Debra K. Menke proudly announces the establishment of DKM Aesthetics, an unconventional distribution company positioned to change the game in the aesthetics industry. Wi
Canadian Investment Regulatory Organization Trade Resumption – METL
VANCOUVER, BC, Jan. 19, 2024 /CNW/ – Trading resumes in: Company: Metalite Resources Inc. CSE Symbol: METL All Issues: Yes Resumption (ET): 3:00 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are impl
Government Aid and Broadband/FTTH Plans in Europe and the U.S. – Exploration of key trends and strategies in government plans for FTTH technology
DUBLIN, Jan. 19, 2024 /PRNewswire/ — The “Government Aid and Broadband/FTTH Plans: Where are we?” report has been added to ResearchAndMarkets.com’s offering. At a time when digital connectivity significantly drives economic growth, societal inclusion, and technological prog
POLARIS OFF ROAD AND SEBASTIEN LOEB RACING PROVE SUPERIOR WITH RZR PRO R FACTORY, SECURING MONUMENTAL 2024 DAKAR RALLY VICTORY
Xavier de Soultrait and Co-Pilot Martin Bonnet Navigated the Polaris RZR Pro R Factory to Two Stage Wins in Route to the Overall SSV T4 Category Victory MINNEAPOLIS, Jan. 19, 2024 /PRNewswire/ — Polaris Off Road made a triumphant return to the winner’s circle at the 46th Edition of the D
The House of Angostura® kicks off the countdown to its bicentennial celebrations.
PORT OF SPAIN, Trinidad, Jan. 20, 2024 /PRNewswire/ — The House of Angostura® prepares to celebrate as it counts down to its 200-year anniversary in 2024. With just a few weeks into the start of the new year, the House of Angostura® is ramping up preparations for a full year of festivities i
Vet Tix Reaches Historic Milestone of 20+ Million Tickets Distributed to Our Nation’s Heroes
TEMPE, Ariz., Jan. 19, 2024 /PRNewswire/ — Veteran Tickets Foundation (Vet Tix) is ecstatic to announce that the national nonprofit organization has distributed 20+ million free event tickets to our nation’s heroes in cities across America. The value of the tickets is over $1.2 billio
Shareholder Alert: Ademi LLP investigates whether Kaman Corp. has obtained a Fair Price in its transaction with Arcline
MILWAUKEE, Jan. 19, 2024 /PRNewswire/ — Ademi LLP is investigating Kaman (NYSE: KAMN) for possible breaches of fiduciary duty and other violations of law in its transaction with Arcline. Click here to learn how to join the https://www.ademilaw.com/case/kaman-corp or call Guri Ademi toll-free
U.S. Food and Drug Administration Grants Full Approval for BALVERSA® to Treat Locally Advanced or Metastatic Bladder Cancer with Select Genetic Alterations
BALVERSA® is the First and Only Targeted Therapy for Patients with Locally Advanced or Metastatic Urothelial Carcinoma and Susceptible Fibroblast Growth Factor Receptor Alterations Phase 3 THOR Study Showed a 36 Percent Reduction in the Risk of Death with BALVERSA® Versus Chemotherapy in Patient
